Author:
Leegaard Anne,Gregersen Pernille A.,Nielsen Trine Ø.,Bjerre Jesper V.,Handrup Mette M.
Subject
Genetics (clinical),Genetics,General Medicine
Reference14 articles.
1. Hypertrophic cardiomyopathy in noonan syndrome treated by MEK-inhibition;Andelfinger;J. Am. Coll. Cardiol.,2019
2. Gain-of-function mutations in RIT1 cause noonan syndrome, a RAS/MAPK pathway syndrome;Aoki;Am. J. Hum. Genet.,2013
3. Biochemical classification of disease-associated mutants of RAS-like protein expressed in many tissues (RIT1);Fang;J. Biol. Chem.,2016
4. Phase 1 Trial of Trametinib Alone and in Combination with Dabrafenib in Children and Adolescents with Relapsed Solid Tumors or Neurofibromatosis Type 1 (NF1) Progressive Plexiform Neurofibromas (PN);Geoerger,2018
5. K-RasV14I recapitulates noonan syndrome in mice;Hernández-Porras;Proc. Natl. Acad. Sci. U. S. A.,2014
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献